The tiny country has announced its enthusiasm for getting into the off-world resource-extraction business. Trouble is, that business doesn’t exist yet.
Mechanical engineers have developed a new helmet design that tackles a key contributor to brain injury.
The company trying to be the first to turn the powerful gene-editing tool CRISPR into medicine faces a number of hurdles.
A state-owned chemical corporation’s $43 billion proposed acquisition reflects the country’s sizable concerns about food security.
As we get older, some of our cells stop dividing. Are these derelicts a reason we age?
Researchers have begun human clinical trials for a device, inspired by woodpeckers, that’s meant to keep the brain from moving around so much inside the skull when it gets hit.
A challenge by DARPA asks scientists to develop ways to record from a million neurons at a time.
The conglomerate that owns Google burned up nearly $4 billion in 2015 on its wildest technological bets such as self-driving cars.
A British government panel has given the green light to a team of researchers who want to use CRISPR to alter human embryos.
Ted Cruz is betting big on the latest in personalized messaging, and so far it’s paying off.